Early phase clinical and biological markers associated with subclinical atherosclerosis measured at 7 years of evolution in an early inflammatory arthritis cohort

Clinical and Experimental Rheumatology

Volumn 34, Issue 1, 2016, Pages 58-67

  Vandhuick, Thibault ^a   Allanore, Yannick ^b   Borderie, Didier ^b   Louvel, Jean Pierre ^c   Fardellone, Patrice ^d   Dieudé, Philippe ^b   Goëb, Vincent ^d   Clavel, Gaëlle ^e,h   Boissier, Marie Christophe ^e   Jouen, Fabienne ^f   Boumier, Patrick ^d   Allart, Jean Dominique ^g   Mejjad, Othmane ^c   Pouplin, Sophie ^c   Jan, Mary ^c   Ménard, Jean François ^c   Loët, Xavier Le ^a   Vittecoq, Olivier ^a  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c ROUEN UNIVERSITY HOSPITAL   (France)

^d AMIENS UNIVERSITY HOSPITAL   (France)

^e AVICENNE HOSPITAL   (France)

^f UNIVERSITY OF ROUEN   (France)

^g Clinique Pauchet   (France)

^h FONDATION OPHTALMOLOGIQUE ADOLPHE DE ROTHSCHILD   (France)

Author keywords

Atherosclerosis; Cardiovascular disease; Early arthritis; Rheumatoid arthritis; Undifferentiated arthritis

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; ANGIOPOIETIN 1; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CD40 LIGAND; CORTICOSTEROID; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HYDROXYCHLOROQUINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; RHEUMATOID FACTOR; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; AUTACOID; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROMA; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; ENDOTHELIAL DYSFUNCTION; FEMALE; GENETIC MARKER; HUMAN; HYPERTENSION; INFLAMMATION; LIPID OXIDATION; LYMPHOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; ONSET AGE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; RISK FACTOR; SWOLLEN JOINT COUNT; AGED; ARTHRITIS; ASYMPTOMATIC DISEASE; BLOOD; CAROTID ARTERY DISEASES; CLINICAL TRIAL; FRANCE; IMMUNOLOGY; JOINT; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; ODDS RATIO; PATHOLOGY; PROTECTION; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; TIME FACTOR;

ADULT; AGED; ARTHRITIS; ASYMPTOMATIC DISEASES; BIOMARKERS; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; FEMALE; FRANCE; HUMANS; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION MEDIATORS; JOINTS; LOGISTIC MODELS; MALE; METHOTREXATE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PROSPECTIVE STUDIES; PROTECTIVE FACTORS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 84958786978     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. MEUNE C, TOUZÉ E, TRINQUART L, ALLANORE Y: Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies. Rheumatology 2009; 48:1309-13.
2. MEUNE C, TOUZÉ E, TRINQUART L, ALLANORE Y: High risk of clinical cardiovascular events in rheumatoid arthritis:Levels of associations of myocardial infarction and stroke through a systematic review and meta-analysis. Arch Cardiovasc Dis 2010; 103: 253-61.
3. NICOLA PJ, MARADIT-KREMERS H, ROGER VL et al.: The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Arthritis Rheum 2005; 52: 412-20.
4. HOLMQVIST ME, WEDREN S, JACOBSSON LT et al.: Rapid increase in myocardial infarction risk following diagnosis of rheumatoid arthritis amongst patients diagnosed between 1995 and 2006. J Intern Med 2010; 268: 578-85.
5. SOLOMON DH, KARLSON EW, RIMM EB et al.: Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003; 107: 1303-7.
6. VAN HALM VP, PETERS MJ, VOSKUYL AE et al.: Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease, a cross sectional study. The CARRE Investigation. Ann Rheum Dis 2009; 68: 1395-400.
7. PHAM T, GOSSEC L, CONSTANTIN A et al.: Cardiovascular risk and rheumatoid arthritis:clinical practice guidelines based on published evidence and expert opinion. Joint Bone Spine 2006; 73: 379-87.
8. PETERS MJ, SYMMONS DP, McCAREY D et al.: EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis or other forms of inflammatory arthritis. Ann Rheum Dis 2010; 69: 325-31.
9. CAMPUZANO R, MOYA JL, GARCÍA-LLEDÓ A et al.: Endothelial dysfunction, intimamedia thickness and coronary reserve in relation to risk factors and Framingham score in patients without clinical atherosclerosis. J Hypertens 2006; 24: 1581-8.
10. GREENLAND P, ALPERT JS, BELLER GA et al.: 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults. A report of the american college of cardiology foundation/american heart association task force on practice guidelines. J Am Coll Cardiol 2010 Dec; 56: e50-103.
11. van SIJL AM, PETERS MJ, KNOL DK et al.: Carotid intima-media thickness in rheumatoid arthritis as compared to control subjects:a meta-analysis. Semin Arthritis Rheum 2011; 40: 389-97.
12. GONZALEZ-JUANATEY C, LLORCA J, MARTIN J, GONZALEZ-GAY MA: Carotid intima-media thickness predicts the development of cardiovascular events in patients with rheumatoid arthritis. Semin Arthritis Rheum 2009; 38: 366-71.
13. GONZALEZ-GAY MA, GONZALEZ-JUANATEY C, PIÑEIRO A, GARCIA-PORRUA C, TESTA A, LLORCA J: High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis. J Rheumatol 2005; 32: 1219-23.
14. GONZÁLEZ-JUANATEY C, LLORCA J, GONZÁLEZ-GAY MA: Correlation between endothelial function and carotid atherosclerosis in rheumatoid arthritis patients with longstanding disease. Arthritis Res Ther 2011; 13: R101.
15. BERLINER JA, NAVAB M, FOGELMAN AM et al.: Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation 1995; 91: 2488-96.
16. WILLERSON JT, RIDKER PM: Inflammation as a cardiovascular risk factor. Circulation 2004; 109: 2-10.
17. JIALAL I, DEVARAJ S, VENUGOPAL SK: C-reactive protein: risk marker or mediator in atherothrombosis? Hypertension 2004; 44:6-11.
18. PASCERI V, YEH ET: A tale of two diseases:atherosclerosis and rheumatoid arthritis. Circulation 1999; 100: 2124-6.
19. +CD28-T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients. Circulation 2004; 109:2744-8.
20. CLAVEL G, BESSIS N, BOISSIER MC: Recent data on the role for angiogenesis in rheumatoid arthritis. Joint Bone Spine 2003; 70:321-6.
21. Le LOËT X, BRAZIER M, MEJJAD O et al.:Serum IgA rheumatoid factor and pyridinoline in very early arthritis as predictors of erosion(s) at two years: a simple model of prediction from a conservatively treated community- based inception cohort. Arthritis Care Res 2010; 62: 1739-47.
22. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
23. RANGANATH VK, YOON J, KHANNA D et al.: Comparison of composite measures of disease activity in an early seropositive rheumatoid arthritis cohort. Ann Rheum Dis 2007; 66: 1633-40.
24. HAN TS, SEIDELL JC, CURRALL JE, MORRISON CE, DEURENBERG P, LEAN ME: The influences of height and age on waist circumference as an index of adiposity in adults. Int J Obes Relat Metab Disord 1997; 21: 83-9.
25. GOËB V, DIEUDÉ P, DAVEAU R et al.: Contribution of PTPN22 1858T, TNFRII 196R and HLA-shared epitope alleles with rheumatoid factor and anti-citrullinated protein antibodies to very early rheumatoid arthritis diagnosis. Rheumatology 2008; 47:1208-12.
26. van der HEIJDE DM: How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol 1999; 26: 743-5.
27. TOUBOUL PJ, HENNERICI MG, MEAIRS S et al.: Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis 2007; 23: 75-80.
28. ALETAHA D, NEOGI T, SILMAN AJ et al.: 2010 Rheumatoid arthritis classification criteria:an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010; 62: 2569-81.
29. EVANS MR, ESCALANTE A, BATTAFARANO DF, FREEMAN GL, O'LEARY DH, Del RINCON I: Carotid atherosclerosis predicts incident acute coronary syndromes in rheumatoid arthritis. Arthritis Rheum 2011; 63: 1211-20.
30. CORRALES A, PARRA JA, GONZALEZJUANATEY C et al.: Cardiovascular risk stratification in rheumatic diseases: carotid ultrasound is more sensitive than Coronary Artery Calcification Score to detect subclinical atherosclerosis in patients with rheumatoid arthritis. Ann Rheum Dis 2013; 72: 1764-70.
31. CORRALES A, GONZÁLEZ-JUANATEY C, PEIRÓ ME, BLANCO R, LLORCA J, GONZÁ-LEZ-GAY MA: Carotid ultrasound is useful for the cardiovascular risk stratification of patients with rheumatoid arthritis: results of a population-based study. Ann Rheum Dis 2014; 73: 722-7.
32. CHUNG CP, OESER A, RAGGI P et al.:Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. Arthritis Rheum 2005; 52: 3045-53.
33. HAFSTRÖM I, ROHANI M, DENEBERG S, WÖRNERT M, JOGESTRAND T, FROSTEGÅRD J: Effects of low-dose prednisolone on endothelial function, atherosclerosis, and traditional risk factors for atherosclerosis in patients with rheumatoid arthritis - a randomized study. J Rheumatol 2007; 34: 1810-6.
34. Del RINCÓN I, FREEMAN GL, HAAS RW, O'LEARY DH, ESCALANTE A: Relative contribution of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosis. Arthritis Rheum 2005; 52:3413-23.
35. Del RINCÓN I, O'LEARY DH, FREEMAN GL, ESCALANTE A: Acceleration of atherosclerosis during the course of rheumatoid arthritis. Atherosclerosis 2007; 195: 354-60.
36. KUMEDA Y, INABA M, GOTO H et al.: Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis. Arthritis Rheum 2002; 46: 1489-97.
37. ABU-SHAKRA M, POLYCHUCK I, SZENDRO G et al.: Duplex study of the carotid and femoral arteries of patients with rheumatoid arthritis:a controlled study. Semin Arthritis Rheum 2005; 35: 18-23.
38. DESSEIN PH, TOBIAS M, VELLER MG: Metabolic syndrome and subclinical atherosclerosis in rheumatoid arthritis. J Rheumatol 2006; 33: 2425-32.
39. AJEGANOVA S, EHRNFELT C, ALIZADEH R et al.: Longitudinal levels of apolipoproteins and antibodies against phosphorylcholine are independently associated with carotid artery atherosclerosis 5 years after rheumatoid arthritis onset-a prospective cohort study. Rheumatology 2011; 50: 1785-93.
40. Del PORTO F, LAGANA B, LAI S et al.: Response to anti-tumour necrosis factor alpha blockade is associated with reduction of carotid intima-media thickness in patients with active rheumatoid arthritis. Rheumatology 2007; 46: 1111-5.
41. GUIN A, CHATTERJEE ADHIKARI M, CHAKRABORTY S, SINHAMAHAPATRA P, GHOSH A: Effects of disease modifying anti-rheumatic drugs on subclinical atherosclerosis and endothelial dysfunction which has been detected in early rheumatoid arthritis: 1-year follow-up study. Semin Arthritis Rheum 2013; 43: 48-54.
42. CHATTERJEE ADHIKARI M, GUIN A, CHAKRABORTY S, SINHAMAHAPATRA P, GHOSH A: Subclinical atherosclerosis and endothelial dysfunction in patients with early rheumatoid arthritis as evidenced by measurement of carotid intima-media thickness and flow-mediated vasodilatation: an observational study. Semin Arthritis Rheum 2011; 41: 669-75.
43. SANDOO A, KITAS GD: Current perspectives on the assessment of vascular function and morphology in rheumatoid arthritis. Int J Clin Rheumatol 2013; 8: 1-3.
44. SANDOO A, CHANCHLANI N, HODSON J, SMITH JP, DOUGLAS KM, KITAS GD: Classical cardiovascular disease risk factors associate with vascular function and morphology in rheumatoid arthritis: a six-year prospective study. Arthritis Res Ther 2013; 15: R203.
45. DESSEIN PH, JOFFE BI, VELLER MG et al.: Traditional and nontraditional cardiovascular risk factors are associated with atherosclerosis in rheumatoid arthritis. J Rheumatol 2005; 32: 435-42.
46. del RINCÓN I, O'LEARY DH, HAAS RW, ESCALANTE A: Effect of glucocorticoids on the arteries in rheumatoid arthritis. Arthritis Rheum 2004; 50: 3813-22.
47. CHOI HK, HERNÁN MA, SEEGER JD, ROBINS JM, WOLFE F: Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 2002; 359: 1173-7.
48. NAGATA-SAKURAI M, INABA M, GOTO H et al.: Inflammation and bone resorption as independent factors of accelerated arterial wall thickening in patients with rheumatoid arthritis. Arthritis Rheum 2003; 48: 3061-7.
49. VAUDO G, MARCHESI S, GERLI R et al.: Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity. Ann Rheum Dis 2004; 63: 31-5.
50. PARK YB, AHN CW, CHOI HK et al.:Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound. Arthritis Rheum 2002; 46: 1714-9.
51. DAZA L, AGUIRRE M, JIMENEZ M, HERRERA R, BOLLAIN JJ: Common carotid intima- media thickness and von Willebrand factor serum levels in rheumatoid arthritis female patients without cardiovascular risk factors. Clin Rheumatol 2007; 26: 533-7.
52. del RINCÓN I, HAAS RW, POGOSIAN S, ESCALANTE A: Lower limb arterial incompressibility and obstruction in rheumatoid arthritis. Ann Rheum Dis 2005; 64: 425-32.
53. ROMAN MJ, DEVEREUX RB, SCHWARTZ JE et al.: Arterial stiffness in chronic inflammatory diseases. Hypertentsion 2005; 46: 194-9.
54. AHMED HM, YOUSSEF M, MOSAAD YM: Antibodies against oxidized low-density lipoprotein are associated with subclinical atherosclerosis in recent-onset rheumatoid arthritis. Clin Rheumatol 2010; 29: 1237-43.
55. GONZALEZ-GAY MA, GONZALEZ-JUANATEY C, LOPEZ-DIAZ MJ et al.: HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum 2007; 57: 125-32.
56. GONZÁLEZ-GAY MA, GONZÁLEZ-JUANATEY C, MIRANDA-FILLOY JA, GARCÍA-UNZUETA MT, LLORCA J: Lack of association between carotid intima-media wall thickness and carotid plaques and markers of endothelial cell activation in rheumatoid arthritis patients undergoing anti-TNF therapy. Acta Reumatol Port 2012; 37: 155-9.
57. MEYER O, LABARRE C, DOUGADOS M et al.: Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five-year radiographic damage. Ann Rheum Dis 2003; 62: 120-6.
58. LÓPEZ-LONGO FJ, OLIVER-MIÑARRO D, de la TORRE I et al.: Association between anticyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis. Arthritis Rheum 2009; 61:419-24.
59. van MAAREN MC, BERENDSEN ML, ARTS EE, DEN BROEDER AA, POPA CD, FRANSEN J: Anti-CCP: no risk factor for 10-year cardiovascular morbidity in a large cohort of rheumatoid arthritis patients (abstract). Ann Rheum Dis 2015; 74: 426-7.
60. LOPEZ-MEJIAS R, CORRALES A, GENRE F et al.: Angiopoietin-2 serum levels correlate with severity, early onset and cardiovascular disease in patients with rheumatoid arthritis. Clin Exp Rheumatol 2013; 31: 761-6.
61. DESSEIN PH, LOPEZ-MEJIAS R, GONZALEZJUANATEY C et al.: Independent relationship of osteoprotegerin concentrations with endothelial activation and carotid atherosclerosis in patients with severe rheumatoid arthritis. J Rheumatol 2014; 41: 429-36.
62. LOPEZ-MEJIAS R, UBILLA B, GENRE F et al.: Osteoprotegerin concentrations relate independently to established cardiovascular disease in rheumatoid arthritis. J Rheumatol 2015; 42: 39-45.
63. VANDHUICK T, PAVY S, Da SILVA LF, VITTECOQ O, DOUGADOS M, Le LOËT X: Marqueurs associés à l'athérome infraclnique dans la polyarthrite rhumatoïde; analyse systématique de la littérature. Rev Rhum 2005; 73: 1089-90.
64. GONZALEZ-JUANATEY C, VAZQUEZ-RODRIGUEZ TR, MIRANDA-FILLOY JA et al.: Anti-TNF-alpha-adalimumab therapy is associated with persistent improvement of endothelial function without progression of carotid intima-media wall thickness in patients with rheumatoid arthritis refractory to conventional therapy. Mediators Inflamm 2012; 2012: 574817.
65. GONZALEZ-JUANATEY C, LLORCA J, GARCIA-PORRUA C, MARTIN J, GONZALEZGAY MA: Effect of anti-tumor necrosis factor alpha therapy on the progression of subclinical atherosclerosis in severe rheumatoid arthritis. Arthritis Rheum 2006; 55: 150-3.
66. GROVER S, SINHA RP, SINGH U, TEWARI S, AGGARWAL A, MISRA R: Subclinical atherosclerosis in rheumatoid arthritis in India. J Rheumatol 2006; 33: 244-7.
67. WÅLLBERG-JONSSON S, OHMAN M, RANTAPÄÄ-DAHLQVIST S: Which factors are related to the presence of atherosclerosis in rheumatoid arthritis? Scand J Rheumatol 2004; 33: 373-9.